RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 47 filers reported holding RECRO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,814,822 | -56.8% | 10,266,144 | +1.4% | 0.71% | -53.0% |
| Q2 2023 | $11,138,758 | +5.8% | 10,126,144 | +14.5% | 1.51% | +6.1% |
| Q1 2023 | $10,526,802 | -20.1% | 8,846,052 | 0.0% | 1.42% | -25.0% |
| Q4 2022 | $13,180,617 | +44.1% | 8,846,052 | +57.7% | 1.90% | +36.8% |
| Q3 2022 | $9,144,000 | +105.0% | 5,609,689 | 0.0% | 1.39% | +97.7% |
| Q2 2022 | $4,460,000 | -51.2% | 5,609,689 | +10.4% | 0.70% | -40.3% |
| Q1 2022 | $9,147,000 | +5.3% | 5,081,901 | 0.0% | 1.18% | +35.1% |
| Q4 2021 | $8,690,000 | -1.2% | 5,081,901 | +19.0% | 0.87% | +1.0% |
| Q3 2021 | $8,794,000 | -10.8% | 4,269,081 | 0.0% | 0.86% | -11.3% |
| Q2 2021 | $9,862,000 | +803.1% | 4,269,081 | +991.0% | 0.97% | +697.5% |
| Q1 2021 | $1,092,000 | – | 391,304 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |